Skip to main content
. 1999 Sep;6(5):751–755. doi: 10.1128/cdli.6.5.751-755.1999

TABLE 4.

Cytokine expression in HPV-positive subjectsa

Subject Minimum no. of months with positive HPV testb HPV type Result of test forf:
IFN-γ IL-4 TNF IL-12
w 0 (New)c MM8 + + + +
x 0 (New) Untyp.e + + + +
y 0 (New) Untyp. + +
z 0 (New) MM8 + + +
aa 0 (New) 18 + +
bb 0 (New) Untyp. +
cc 0 (New) MM8 + + +
dd 4  16 + +
ee 9  16 + + +
ff 12  16
gg 20  16 + +
hh 22  58 +
ii 22  16 + + +
jj 46  31/33/35d + + +
kk 49  16 + + +
a

In cases where cytokine data was available for more than one visit by a subject, only the first visit with cytokine data was included in this cross-sectional analysis. 

b

Since HPV infection was acquired at an indeterminate time prior to the first positive study visit, the actual duration of infection may be longer. 

c

New, a newly positive test at the study visit shown. 

d

Positive on a probe mix which recognizes these three types. 

e

Untyp., HPV positive by generic HPV probe but not positive for any of the types tested. 

f

Overall, 60% of these subjects had the Th1 cytokine pattern, defined as the expression of IFN-γ and absence of IL-4 by RT-PCR. Percentages of subjects expressing IFN-γ, IL-4, TNF, and IL-12 were 80, 20, 93, and 47%, respectively.